In this episode of Healthcare Happy Hour, David Saltzman sits down with Jennifer Berman, chief legal officer of Lumelight, to break down the key provisions of the Consolidated Appropriations Act (CAA) 2026. The discussion focuses on expanded transparency requirements, including new prescription drug reporting and significant changes to compensation disclosure rules impacting brokers, TPAs, and other health plan vendors. Jennifer also explores the growing fiduciary responsibilities for plan sponsors, increased litigation risk, and the need for structured governance and documentation. The conversation highlights both the challenges and opportunities these evolving regulations present for plan sponsors, vendors, and advisors.